Form 8-K Oxford Immunotec Global For: Mar 01

Go back to Form 8-K Oxford Immunotec Global For: Mar 01

Oxford (OXFD) Misses Q4 EPS by 1c

March 1, 2016 7:47 AM EST

Oxford (NASDAQ: OXFD) reported Q4 EPS of ($0.29), $0.01 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $16 million versus the consensus estimate of $16.34 million.

GUIDANCE:

Oxford sees Q1 2016 revenue of $16.6-17.3 million, versus the consensus of $17.7... More